검색
InflaRx NV
IFRX관심 목록에 추가
2.090USD
-0.080-3.69%
종가 09-09 16:00（ET）
308.00M시가총액
손실P/E TTM
자세한 내용은 InflaRx NV 회사
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.
InflaRx NV 프로필
종목 코드 IFRX
회사 이름InflaRx NV
상장일Nov 08, 2017
CEORiedemann (Niels C)
직원 수74
유형Ordinary Share
회계 연도 종료Nov 08
주소Winzerlaer Str. 2
도시JENA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Germany
우편 번호07745
전화493641508180
웹사이트https://www.inflarx.de/
종목 코드 IFRX
상장일Nov 08, 2017
CEORiedemann (Niels C)
InflaRx NV의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Nicolas Fulpius
Mr. Nicolas Fulpius
Independent Chairman of the Board
Independent Chairman of the Board
490.05K
+4.52%
Mr. Richard Brudnick
Mr. Richard Brudnick
Non-Executive Independent Director
Non-Executive Independent Director
50.00K
--
Dr. Thomas Taapken
Dr. Thomas Taapken
Chief Financial Officer
Chief Financial Officer
3.50K
--
Prof. Niels C. Riedemann, M.D., Ph.D.
Prof. Niels C. Riedemann, M.D., Ph.D.
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Prof. Renfeng Guo
Prof. Renfeng Guo
Chief Scientific Officer, Executive Director
Chief Scientific Officer, Executive Director
--
--
Mr. Mark Kubler
Mr. Mark Kubler
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Anthony Gibney
Mr. Anthony Gibney
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Camilla Chong
Dr. Camilla Chong
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Derval O'Carroll
Ms. Derval O'Carroll
Senior Vice President, Global Head of Regulatory Affairs and Compliance
Senior Vice President, Global Head of Regulatory Affairs and Compliance
--
--
Ms. Hege Hellstrom
Ms. Hege Hellstrom
Non-Executive Independent Director
Non-Executive Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Nicolas Fulpius
Mr. Nicolas Fulpius
Independent Chairman of the Board
Independent Chairman of the Board
490.05K
+4.52%
Mr. Richard Brudnick
Mr. Richard Brudnick
Non-Executive Independent Director
Non-Executive Independent Director
50.00K
--
Dr. Thomas Taapken
Dr. Thomas Taapken
Chief Financial Officer
Chief Financial Officer
3.50K
--
Prof. Niels C. Riedemann, M.D., Ph.D.
Prof. Niels C. Riedemann, M.D., Ph.D.
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Prof. Renfeng Guo
Prof. Renfeng Guo
Chief Scientific Officer, Executive Director
Chief Scientific Officer, Executive Director
--
--
Mr. Mark Kubler
Mr. Mark Kubler
Non-Executive Independent Director
Non-Executive Independent Director
--
--
자주 묻는 질문
InflaRx NV의 상위 5대 주주는 누구인가요?
InflaRx NV의 상위 5대 주주는 다음과 같습니다: Mr. Nicolas Fulpius
InflaRx NV(IFRX)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, InflaRx NV의 주식을 보유한 기관은 총 82곳이며, 이들이 보유한 주식의 총 가치는 약 19.59M로 전체 발행 주식의 13.30%를 차지합니다. 이는 2025Q4 대비 -4596250.00 증가한 수치입니다.